Related Experiment Video
Updated: Jul 6, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Pharmacological neuroprotective therapy for acute spinal cord injury: state of the art
1Unidad de Investigación Médica en Enfermedades Neurológicas, HE, CMN Siglo XXI, IMSS, Av. Cuauhtemoc No. 330, Col. Doctores, CP 06720, México City, México.
Abstract:
After spinal cord injury, a number of destructive events developed immediately after the primary insult increase tissue damage. Several therapeutic approaches are directed to neutralize these phenomena. The present manuscript revises diverse pharmacological treatments used to promote neuroprotection, both in clinical and experimental acute spinal cord injuries.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Cardiopulmonary Resuscitation IV: Pharmacological Management
Spinal Cord Injury ll: Pathophysiology

